Sepsis is one of the major diseases in intensive care worldwide.Although sepsis has made some progress in recent years in the diagnosis and treatment of sepsis,it is still the first cause of death in the intensive care unit.Sepsis,the most vulnerable to involvement of lung tissue,often complicated by acute respiratory distress syndrome (ARDS).Mechanism of ARDS is very complex,and the current judge the disease development and prognosis is still limited.Biological markers can help to determine the development of patients with ARDS,assessment of treatment and prognosis.The aim of this study was to investigate the effects of various biomarkers on the pathophysiology,diagnosis,treatment and prognosis of sepsis ARDS,evaluate its value in the diagnosis and treatment of ARDS,and provide a new method for the diagnosis and treatment of sepsis ARDS Ideas and methods.%脓毒症(sepsis)是目前全球范围内重症监护病房(ICU)的主要疾病之一,虽然近年来针对脓毒症的诊断及治疗等相关研究有一定进展,但其仍然是ICU内的首位死因.脓毒症时,肺脏组织最易受累,常并发急性呼吸窘迫综合征(ARDS).ARDS发生机制十分复杂,目前判断其疾病的发展及预后能力仍然有限.生物学标志物有助于判断脓毒症患者ARDS的发生发展、评估治疗及判断预后.本文旨在综述各种生物学标志物对脓毒症ARDS的病理生理、诊断、治疗及判断预后等的影响,评估其在ARDS诊疗中的价值,为脓毒症ARDS的诊断和治疗提供新的思路和方法.
展开▼
